Transplantation, AutologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseStem CellsMultiple MyelomaMelphalanBone MarrowCombined Modality TherapyTreatment OutcomeRemission InductionBone Marrow CellsWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsLiver TransplantationHematologic NeoplasmsRecurrenceHematopoietic Stem CellsGraft SurvivalCyclophosphamideBusulfanTransplantation ChimeraSalvage TherapyDisease-Free SurvivalMyeloablative AgonistsBone Marrow PurgingLymphoma, Non-HodgkinTissue DonorsHodgkin DiseaseEtoposideHematopoietic Stem Cell MobilizationCytarabineSurvival RateRetrospective StudiesCarmustineSurvival AnalysisKidney TransplantationHistocompatibility TestingLeukemiaMesenchymal Stem Cell TransplantationVincristineThiotepaCord Blood Stem Cell TransplantationHistocompatibilityTime FactorsCell TransplantationAntigens, CD34Leukemia, Myeloid, AcuteFollow-Up StudiesImmunosuppressive AgentsAnemia, AplasticPrognosisGranulocyte Colony-Stimulating FactorTransplantation, IsogeneicAmyloidosisHematopoiesisMyelodysplastic SyndromesHeart TransplantationLymphoma, Mantle-CellTransplantation ImmunologyEmbryonic Stem CellsGraft RejectionDexamethasoneCell DifferentiationLymphomaHepatic Veno-Occlusive DiseaseBoronic AcidsGraft vs Leukemia EffectAntineoplastic Agents, AlkylatingLung TransplantationBone and BonesPyrazinesLymphoma, FollicularNeoplasm, ResidualAdult Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoneLeukemia, MyeloidAntibodies, Monoclonal, Murine-DerivedDoxorubicinLeukapheresisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseHLA AntigensPodophyllotoxinImmunosuppressionOrgan TransplantationHematologic DiseasesGraft vs Tumor EffectT-LymphocytesLymphocyte TransfusionAutograftsThalidomideLymphocyte DepletionLymphoma, T-Cell, PeripheralMice, Inbred C57BL